Page last updated: 2024-08-25

zoledronic acid and Hyperparathyroidism, Primary

zoledronic acid has been researched along with Hyperparathyroidism, Primary in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Shane, E; Walker, MD1
Kiviniemi, U; Koski, AM; Löyttyniemi, E; Ryhänen, EM; Schalin-Jäntti, C; Välimäki, MJ1
Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B1
Argüelles Jiménez, I; Carrillo García, P; García Fernández, H; Quevedo Juanals, J; Serra Soler, G1

Reviews

2 review(s) available for zoledronic acid and Hyperparathyroidism, Primary

ArticleYear
Hypercalcemia: A Review.
    JAMA, 2022, 10-25, Volume: 328, Issue:16

    Topics: Calcium; Coma; COVID-19; Dehydration; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Immune Checkpoint Inhibitors; Nausea; Neoplasms; Pamidronate; Parathyroid Hormone; SARS-CoV-2; Sleepiness; Sodium Chloride Symporter Inhibitors; Vitamin A; Vitamin D; Vomiting; Zoledronic Acid

2022
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review.
    BMC endocrine disorders, 2015, Jan-28, Volume: 15

    Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid

2015

Trials

1 trial(s) available for zoledronic acid and Hyperparathyroidism, Primary

ArticleYear
Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study.
    European journal of endocrinology, 2021, Aug-27, Volume: 185, Issue:4

    Topics: Aged; Bone Density; Bone Density Conservation Agents; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Female; Finland; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Osteoporosis; Parathyroidectomy; Postoperative Period; Treatment Outcome; Zoledronic Acid

2021

Other Studies

2 other study(ies) available for zoledronic acid and Hyperparathyroidism, Primary

ArticleYear
[Primary hyperparathyroidism. An alternative to the surgery].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3

    Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid

2009
[Parathyroid crisis due to a cystic parathyroid adenoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:3

    Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Colectomy; Colonic Diseases; Consciousness Disorders; Cysts; Diagnostic Imaging; Diphosphonates; Emergencies; Female; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Intestinal Perforation; Kidney Calculi; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Thyroidectomy; Zoledronic Acid

2011